President
YCT Scientific Inc
Dr. Yu Chung Tsang is a consultant in pharmacokinetics, biopharmaceutics and biostatistics, with specialty in the areas of PK bioequivalence and clinical endpoint study design and data analysis/interpretation. He obtained his Bachelor’s degree in Pharmacy in 1984 and PhD degree in Pharmacokinetics in 1990 from the University of Toronto. Prior to starting his consulting business, he worked for Apotex Inc. for over 33 years, with his last position being the Chief Scientific Officer, Biopharmaceutics and Biostatistics. His main responsibilities were to provide pharmacokinetic and statistical advice in preparing protocol and study reports for pharmacokinetic/pharmacodynamic and clinical studies of complex drug and biosimilar products, and in the design of bioequivalence/clinical endpoint studies and the analysis of data for the development of traditional generic drug products in the Apotex group of companies. In his career, he was involved with the design and data analysis of over one thousand bioequivalence/clinical studies for the registration of complex drug and biosimilar products and over 300 traditional generic drugs in Canada, US, EU, and many other international marketplaces. He also provided statistical support in clinical trials of new chemical entities at ApoPharma. Dr. Tsang was the Past Chair of the Bioequivalence Committee in the Canadian Generic Pharmaceutical Association, and the Past Chair of the Generic Pharmaceuticals Focus Group of the American Association of Pharmaceutical Scientists. He was also a member of the Bioequivalence Working Group of the Medicines for Europe. Aside from his industrial experience, he also holds an appointment (status only) at the Leslie Dan Faculty of Pharmacy, University of Toronto.
Disclosure information not submitted.
Monday, September 9, 2024
1:30 PM – 3:00 PM ET
Monday, September 9, 2024
1:30 PM – 3:00 PM ET